您的位置: 首页 > 农业专利 > 详情页

Specific Chimeric Antigen Receptor T Cells Targeting To NKG2DL, Its Preparation Method and Application Thereof
专利权人:
NANJING KAEDI BIOTECH INC
发明人:
Hongjiu DAI,Bin SUN,Xudong ZHAO
申请号:
US16116953
公开号:
US20180369285A1
申请日:
2018.08.30
申请国别(地区):
US
年份:
2018
代理人:
摘要:
A chimeric antigen receptor targeting to NKG2DL, its encoding sequence, and its modified immune response cells, and the preparation and application of them. This invention constructs a chimeric antigen receptor targeting to NKG2DL and its modified immune response cell based on the NKG2D molecule, and the novel modified immune response cells can effectively target a variety of tumor cells, especially the expression of NKG2DL positive tumor cells, and can be used to prepare preparations for the treatment of tumors. The preparation of the modified immune response cells of the target NKG2DL is easy, and the immune response cells modified by the target NKG2DL have high killing rate to the tumor cells.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充